NSF and Alzheimer disease: The opposing directional effects observed for several genes (NSF, SEZ6L2, DOC2A, MAPK3), i.e., elevated expression with pre-symptomatic traits (iAD2, iAging2) but reduced expression in symptomatic AD, may reflect stage-dependent regulatory mechanisms.